Capital Research Global Investors Dexcom Inc Transaction History
Capital Research Global Investors
- $443 Billion
- Q2 2024
A detailed history of Capital Research Global Investors transactions in Dexcom Inc stock. As of the latest transaction made, Capital Research Global Investors holds 11,945,527 shares of DXCM stock, worth $804 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
11,945,527
Previous 13,435,892
11.09%
Holding current value
$804 Million
Previous $1.86 Billion
27.32%
% of portfolio
0.31%
Previous 0.43%
Shares
16 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.13 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.32 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.1 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.03 Billion1.38% of portfolio
-
Sands Capital Management, LLC Arlington, VA10.6MShares$714 Million3.7% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...